Common name
5-methylisoxazole
IUPAC name
5-methylisoxazole
SMILES
o1nccc1C
Common name
5-methylisoxazole
IUPAC name
5-methylisoxazole
SMILES
o1nccc1C
INCHI
InChI=1S/C4H5NO/c1-4-2-3-5-6-4/h2-3H,1H3
FORMULA
C4H5NO
Common name
5-methylisoxazole
IUPAC name
5-methylisoxazole
Molecular weight
83.089
clogP
1.428
clogS
-1.210
Frequency
0.0031
HBond Acceptor
2
HBond Donor
0
Total PolarSurface Area
26.03
Number of Rings
1
Rotatable Bond
0
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00188 | Flucloxacillin |
|
Anti-Bacterial Agents; Penicillins; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Antibacterials for Intramammary Use; Beta-Lactamase Resistant Penicillins; Beta-Lactam Antibacterials, Penicillins; Beta-Lactam Antibacterials, Penicillins, for Intramammary Use; CYP3A4 Inhibitors; | Used to treat bacterial infection by susceptible microorganisms. |
| FDBD00358 | Dicloxacillin |
|
Anti-Bacterial Agents; Penicillins; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Antibacterials for Intramammary Use; Beta-Lactamase Resistant Penicillins; Beta-Lactam Antibacterials, Penicillins; Beta-Lactam Antibacterials, Penicillins, for Intramammary Use; CYP3A4 Inhibitors; | Used to treat infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. |
| FDBD00577 | Oxacillin |
|
Anti-Bacterial Agents; Penicillins; Genito Urinary System and Sex Hormones; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Antibacterials for Intramammary Use; Beta-Lactamase Resistant Penicillins; Beta-Lactam Antibacterials, Penicillins; Beta-Lactam Antibacterials, Penicillins, for Intramammary Use; Antiinfectives and Antiseptics for Intrauterine Use; | Used in the treatment of resistant staphylococci infections. |
| FDBD00869 | Sulfamethoxazole |
|
Anti-Infective Agents; Sulfonamides; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Sulfonamides and Trimethoprim; Intermediate-Acting Sulfonamides; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C8 Inducers; CYP3A4 Inhibitors; | For the treatment bacterial infections causing bronchitis, prostatitis and urinary tract infections. |
| FDBD00947 | Leflunomide |
|
Antirheumatic Agents; Immunosuppressive Agents; Enzyme Inhibitors; Adjuvants; Antineoplastic and Immunomodulating Agents; Selective Immunosuppressants; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C9 Inducers; | For the management of the signs and symptoms of active rheumatoid arthritis (RA) to improve physical function and to slow the progression of structural damage associated with the disease. Has also been used for the prevention of acute and chronic rejection in recipients of solid organ trasnplants and is designated by the FDA as an orphan drug for this use. |
| FDBD00995 | Cloxacillin |
|
Anti-Bacterial Agents; Penicillins; Antibiotics; Ophthalmologicals; Sensory Organs; Genito Urinary System and Sex Hormones; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Antiinfectives; Antibacterials for Intramammary Use; Beta-Lactamase Resistant Penicillins; Beta-Lactam Antibacterials, Penicillins; Beta-Lactam Antibacterials, Penicillins, for Intramammary Use; Antiinfectives and Antiseptics for Intrauterine Use; | Used to treat infections caused by penicillinase-producing staphylococci, including pneumococci, group A beta-hemolytic streptococci, and penicillin G-sensitive and penicillin G-resistant staphylococci. |
| FDBD01091 | Isocarboxazid |
|
Antidepressive Agents; Monoamine Oxidase Inhibitors; Nervous System; Antidepressants; Psychoanaleptics; Monoamine Oxidase Inhibitors, Non-Selective; | May be used to treat major depressive disorder. |
| FDBD01117 | Glisoxepide |
|
Drugs Used in Diabetes; Alimentary Tract and Metabolism; Blood Glucose Lowering Drugs, Excl. Insulins; Sulfonylureas; | For the treatment of diabetes mellitus type 2. |
| FDBD01510 | Parecoxib |
|
Musculo-Skeletal System; Antiinflammatory and Antirheumatic Products, Non-Steroids; Antiinflammatory and Antirheumatic Products; Coxibs; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; CYP3A4 Inhibitors; | Used for short term perioperative pain control. |
9 ,
1
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 4gr0_ligand_1_3.mol2 | 4gr0 | 1 | -5.97 | n1oc(cc1)C | 6 |
| 4gr3_ligand_1_3.mol2 | 4gr3 | 1 | -5.97 | Cc1oncc1 | 6 |
| 2ovz_ligand_1_9.mol2 | 2ovz | 1 | -5.96 | c1(ccno1)C | 6 |
| 4b0g_ligand_frag_0.mol2 | 4b0g | 1 | -5.94 | Cc1ccno1 | 6 |
| 4gql_ligand_1_3.mol2 | 4gql | 1 | -5.94 | n1oc(cc1)C | 6 |
| 4gr8_ligand_1_3.mol2 | 4gr8 | 1 | -5.94 | n1oc(cc1)C | 6 |
| 2yjw_ligand_frag_0.mol2 | 2yjw | 1 | -5.93 | n1ccc(o1)C | 6 |
| 2x6e_ligand_frag_0.mol2 | 2x6e | 1 | -5.74 | Cc1ccno1 | 6 |
100 ,
11
